Effect of polymerization conditions on the network properties of dex-HEMA microspheres and macro-hydrogels

Microplastic label in microencapsulation field - Consequence of shell material selection

Plastics make our lives easier in many ways; however, if they are not appropriately disposed of or recycled, they may end up in the environment where they stay for centuries and degrade into smaller and smaller pieces, called microplastics. Each year, approximately 42000 tonnes of microplastics end up in the environment when products containing them are used. According to the European Chemicals Agency (ECHA) one of the significant sources of microplastics are microcapsules formulated in home care and consumer care products. As part of the EU's plastics strategy, ECHA has proposed new regulations to ban intentionally added microplastics starting from 2022. It means that the current cross-linked microcapsules widely applied in consumer goods must be transformed into biodegradable shell capsules. The aim of this review is to provide the readers with a comprehensive and in-depth understanding of recent developments in the art of microencapsulation. Thus, considering the chemical structure of the capsule shell's materials, we discuss whether microcapsules should also be categorized as microplastic and therefore, feared and avoided or whether they should be used despite the persisting concern.

Study on the Interaction of Plasma-Polymerized Hydrogel Coatings with Aqueous Solutions of Different pH

Amphiphilic hydrogels from mixtures of 2-hydroxyethyl methacrylate and 2-(diethylamino)ethyl methacrylate p(HEMA-co-DEAEMA) with specific pH sensitivity and hydrophilic/hydrophobic structures were designed and polymerized via plasma polymerization. The behavior of plasma-polymerized (pp) hydrogels containing different ratios of pH-sensitive DEAEMA segments was investigated concerning possible applications in bioanalytics. In this regard, the morphological changes, permeability, and stability of the hydrogels immersed in solutions of different pHs were studied. The physico-chemical properties of the pp hydrogel coatings were analyzed using X-ray photoelectron spectroscopy, surface free energy measurements, and atomic force microscopy. Wettability measurements showed an increased hydrophilicity of the pp hydrogels when stored in acidic buffers and a slightly hydrophobic behavior after immersion in alkaline solutions, indicating a pH-dependent behavior. Furthermore, the pp (p(HEMA-co-DEAEMA) (ppHD) hydrogels were deposited on gold electrodes and studied electrochemically to investigate the pH sensitivity of the hydrogels. The hydrogel coatings with a higher ratio of DEAEMA segments showed excellent pH responsiveness at the studied pHs (pH 4, 7, and 10), demonstrating the importance of the DEAEMA ratio in the functionality of pp hydrogel films. Due to their stability and pH-responsive properties, pp (p(HEMA-co-DEAEMA) hydrogels are conceivable candidates for functional and immobilization layers for biosensors.

Synthesis and characterization of arabinoxylan-bis[2-(methacryloyloxy)ethyl] phosphate crosslinked copolymer network by high energy gamma radiation for use in controlled drug delivery applications

Keeping in view the therapeutic important dietary fiber psyllium, herein this research report its potential has been explored for the formation of sterile hydrogel by high energy radiation induced copolymerization of arabinoxylan-poly bis[2-(methacryloyloxy)ethyl] phosphate (BMEP) for use as drug delivery carrier. The polymeric network structure was characterized by 13C NMR, FTIR, TGA/DTG and DSC, XRD and AFM techniques. Release profile of a drug cefuroxime and best fit kinetic model were determined. The blood -polymer interaction, mucosal-polymer adhesion, antioxidant and mechanical properties were also evaluated. The radiation dose influenced the crosslink density and the mesh size of the hydrogel network. Release profile of a drug cefuroxime followed non-Fickian diffusion and best fitted to first order kinetic model. The grafted product was sterile, porous, antioxidant and mucoadhesive in nature and could be explored for controlled and sustained GIT drug delivery applications.

Optimization of the formulation of an original hydrogel-based bone cement using a mixture design

Highly swelling polymers, i.e. superabsorbent hydrogels, are hydrophilic, three dimensional networks that can easily absorb a significant amount water, fluid or drug. They are widely used in various applications such as foods, cosmetics, and medical devices. Bone cements are used in orthopaedics as a filling biomaterial or as a grout enhancing the embedding of a prosthesis into bone and fixation is achieved by mechanical interlock with metal or bone surfaces. Recently, hydrophilic bone cements have attracted the attention for bone tissue-engineering applications. Here a bone cement containing an acrylic hydrogel (HEMA) as a liquid phase and a blend of corn starch, cellulose acetate and bioceramic filler as a solid phase is investigated by means of a mixture design which is a special topic within statistical Design of Experiments (DoE). Output variables of interest, complex shear modulus, compressive modulus and swelling rate related to rheological, mechanical and swelling properties respectively, are measured for each cement formulation. Applying the mixture design strategy enables to assess the impact of the three powder components on each variable of interest and to determine the optimal formulation in order to achieve the required properties of this HEMA-based bone cement, especially the rheology adapted to the desired clinical application, but also appropriate mechanical and swelling properties.

Morphological and Swelling Potential Evaluation of Moringa oleifera Gum/Poly(vinyl alcohol) Hydrogels as a Superabsorbent

Synergistic use of superabsorbent hydrogels has vital contribution to the daily life. This work gives an account of a facile approach to synthesize superabsorbent hydrogels based on Moringa oleifera gum and polyvinyl alcohol cross-linked with borax. Fourier transform infrared, X-ray diffraction, and scanning electron microscopy were employed to characterize the structure, crystallinity, and surface morphologies of the samples. The cross-link density, swelling ratio, reswelling, water retention properties, and salt sensitivity of hydrogels were investigated. Reaction parameters for the hydrogel synthesis were optimized on the basis of water absorbency, and the reaction condition of greater water absorbency after 12 h at room temperature was taken as an ideal condition. Optimum conditions were obtained as [poly(vinyl alcohol) PVA] = 10% (w/v) and [borax] = 1.05 × 10-3 mol/L. Under the optimized conditions, the maximum swelling ratio of MOG/PVA hydrogel reached 1163 g/g in deionized water and 290 g/g in 0.9 wt % NaCl solution. Furthermore, all hydrogels exhibited salt sensitivity and excellent water retention capacity under the high temperature state and displayed smart swelling behaviors in physiological saline solutions. The water absorbency, reusability, and salt sensitivity of the hydrogels give these smart polymer wide promising applications.

Fabrication of a Controlled in Situ Forming Polypeptide Hydrogel with a Good Biological Compatibility and Shapeable Property

A hydrogel is required to have a good biocompatibility, permeability for nutrients, and an easy construction procedure for biomedical applications. In particular, in situ forming hydrogels (ISFHs) have triggered considerable interest in their facile preparation methods. Here, an enzyme-prompted ISF, biodegradable poly(l-lysine)-graft-4-hydroxyphenylacetic acid (PLL-g-HPA) hydrogel in the conditions of horseradish peroxidase (HRP) and hydrogen peroxide (H2O2) and with a good biocompatibility was developed. The gelling time varied from a couple of seconds to several minutes depending on the amounts of catalyst, H2O2, and polymer. Due to the conveniently ISF means, the fabricated hydrogel could be applied in any form according to the need. The hydrogels display a good biological compatibility, as demonstrated in vitro cell culture and attachment experiments. Besides, the remaining NH2 groups in the hydrogel could be further functionalized for various cell research and bioapplications.

Phosphate crosslinked pectin based dual responsive hydrogel networks and nanocomposites: Development, swelling dynamics and drug release characteristics

Potential dual responsive hydrogel networks (PPAD) are fabricated from pectin, poly((2-dimethylamino)ethyl methacrylate)) and phosphate crosslinker bis[2-methacryloyloxy] ethyl phosphate (BMEP) by a simple free radical polymerization. These hydrogel networks are successfully utilized for encapsulation of an anti-cancer drug, 5-fluorouracil (5-FU) and also employed as versatile platforms for production of silver nanoparticles. Fabricated hydrogel networks and silver nanocomposites were characterized by FTIR, SEM, EDX, TEM, DLS, DSC, TGA and XRD. Different polymer network parameters such as M_C¯, χ, ξ and υ_e and diffusion constant (D) were evaluated to assess the drug release profile. The 5FU loaded PPAD hydrogels were used to perform in vitro release studies in both gastric and intestinal conditions of GIT (pH 1.2 & pH 7.4) at two different temperatures (25 and 37°C). On the other hand various kinetic models (zero, first, Higuchi & Koresmeyer-Peppas) have also been employed to fit drug release profile. In addition, the antibacterial activity of PPAD silver nanocomposites were tested against four bacterial species Escherichia coli (-ve), Klebsiella pneumoniae (-ve), Bacillus cereus (+ve) and Staphylococcus aereus (+ve) using zone of inhibition test.

Effect of excipients on the encapsulation efficiency and release of human growth hormone from dextran microspheres

The possibility was investigated to modulate the encapsulation efficiency and release of human growth hormone (hGH) from hydroxyl ethyl methacrylated dextran (dex-HEMA) hydrogel microspheres by using excipients. Microspheres were prepared by polymerization of dex-HEMA in an aqueous two-phase system of this polymer and PEG with or without excipients (Tween 80, pluronic F68, sucrose, NaCl, urea or methionine). High hGH encapsulation efficiencies (50-70%) were obtained for microspheres prepared without excipients and with Tween 80, NaCl or methionine. Substantially lower encapsulation efficiencies (27% and 19%, respectively) were obtained for microspheres prepared in the presence of sucrose and urea, which was attributed to the more favoured partitioning of hGH over the PEG-phase due to higher hydrophobicity of the (partly) denatured hGH. Likely, differences in precipitate size of the encapsulated hGH resulted in different release profiles between microspheres prepared without excipients (biphasic release: 2 days delay time followed by 6 days release) and the release profile for microspheres prepared with Tween 80, pluronic F68, sucrose, NaCl and urea (release over a period of 6-8 days (without a delay time)). Microspheres prepared with methionine showed a concentration-dependent delay time varying from 0 to 2 days followed by almost zero-order release over 6 days, attributed to the effect of methionine on the polymerization of dex-HEMA. Especially, Tween 80 and methionine are attractive excipients since hGH was encapsulated in high yield (60-70%) and the protein was released from the microspheres mainly in its monomeric form without a delay time and with an almost zero-order release over 6-8 days.

Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation

Purpose

To investigate the in vitro in vivo correlation of a sustained release formulation for human growth hormone (hGH) based on hydroxyethyl methacrylated dextran (dex-HEMA) microspheres in Pit-1 deficient Snell dwarf mice and in healthy human volunteers.

Materials and Methods

A hGH-loaded microsphere formulation was developed and tested in Snell dwarf mice (pharmacodynamic study) and in healthy human volunteers (pharmacokinetic study).

Results

Single subcutaneous administration of the microspheres in mice resulted in a good correlation between hGH released in vitro and in vivo effects for the hGH-loaded microsphere formulation similar to daily injected hGH indicating a retained bioactivity. Testing the microspheres in healthy volunteers showed an increase (over 7–8 days) in hGH serum concentrations (peak concentrations: 1–2.5 ng/ml). A good in vitro in vivo correlation was obtained between the measured and calculated (from in vitro release data) hGH serum concentrations. Moreover, an increased serum concentration of biomarkers (insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3) was found again indicating that bioactive hGH was released from the microspheres.

Conclusions

Good in vitro in vivo correlations were obtained for hGH-loaded dex-HEMA microspheres, which is an important advantage in predicting the effect of the controlled drug delivery product in a clinical situations.

Review on Medusa®:a polymer-based sustained release technology for protein and peptide drugs

The polymer-based Medusa system (Flamel Technologies) has been designed for slow release of therapeutic proteins and peptides. The Medusa II consists of a poly L-glutamate backbone grafted with hydrophobic alpha-tocopherol molecules, creating a colloidal suspension of nanoparticles (10 - 50 nm) in water. The sustained drug release is based on reversible drug interactions with hydrophobic nanodomains within the nanoparticles. In vivo, it is suggested that the therapeutic protein is displaced by endogenous proteins present in physiological fluids, leading to a slow drug release. The peak concentration is dramatically decreased and the protein release substantially extended. The Medusa technology has been applied to subcutaneous injection for several therapeutic proteins, such as IL-2 and IFN-alpha(2b), in animal models (rats, dogs, monkeys) and clinical trials in renal cancer (IL-2) and hepatitis C (IFN-alpha(2b)) patients.

Preparation of dextran glassy particles through freezing-induced phase separation

This report demonstrates a novel method to prepare fine polysaccharide glassy particles of uniform sizes under a condition without water/oil and water/air interfacial tension and cross-linking reagents. When a co-solution of dextran and polyethylene glycol (PEG) was frozen gradually, phase separation occurred during which dextran formed the dispersed phase and PEG remained in the continuous part. Fine dextran glassy particles were harvested after lyophilizing this frozen sample, followed by re-dissolving the continuous phase (PEG) in dichloromethane or acetonitrile. Desired mean particle diameter can be achieved within the range between 200 nm and 10 microm by selecting molecular weights of PEG and dextran, concentration of the co-solution, and PEG/dextran ratio. Increase in molecular weights, concentration or PEG/dextran ratio resulted in increase in particle sizes, and the vice versa. The dextran particles prepared as above showed smooth surface under an electron microscope, a phase transition temperature on thermogram, and sank in carbon tetrachloride (density = 1.592 g/ml), indicating that the particle matrix is dense and glassy. This particulate system and its forming process may have wide applications in formulating variety of pharmaceutical dosage forms and medical devices containing delicate biotech therapeutics.

Tissue response in the rat and the mouse to degradable dextran hydrogels

Two types of hydroxyethyl-methacrylated dextran (dex-HEMA) hydrogels differing in crosslink density were compared for local tissue responses and degradation characteristics in mice and rats. Implants (1 mm thick, rat: 10 mm diameter, mouse: 6 mm diameter) varying in degree of HEMA substitution (DS5 and DS13, meaning 5 or 13 HEMA groups per 100 glucose units of dextran) were subcutaneously implanted and tissue responses were evaluated at week 2, 6, and 13 after implantation. In the rat after 2 weeks a slight fibrous capsule was formed composed of macrophages and fibroblasts sometimes accompanied by a minimal infiltrate. Small fragments, surrounded by macrophages and giant cells indicated hydrogel degradation. After 13 weeks DS5 implants were resorbed while parts of the DS13 implants were still present. In the mouse a moderate to strong capsule formation was present at 2 weeks accompanied by inflammatory cells (macrophages and polymorphonuclear granulocytes) and debris. Draining lymph node activation was observed. Skin ulceration was present irrespective of the type of implant. Clear differences in the tissue responses between the rat and mouse were noted, as well as between implants of different degree of substitution. Mice showed a more pronounced early inflammatory response compared with rats, whereas the degradation was more complete in rats than in mice. The differences in histology between the hydrogels disappeared over time at 13 weeks after implantation and similar responses were noted for both types of hydrogels. Both in mice and rats the DS5 hydrogels showed a faster degradation rate than the DS13 hydrogels.

Synthesis and characterization of hyperbranched polyglycerol hydrogels

Hyperbranched polyglycerol (HyPG; M(n) 2000g/mol) was derivatized with glycidyl methacrylate (GMA) in dimethyl sulfoxide using 4-(N,N-dimethylamino)pyridine as a catalyst to obtain methacrylated HyPG (HyPG-MA). The degree of substitution (DS, the percentage of derivatized hydroxyl groups), established by NMR and RP-HPLC, was fully controlled in the range of 0.7-70 by varying the molar ratio of GMA to HyPG in the reaction mixture. This indicates that for e.g. a DS of 28, 9 out of the 32 hydroxyl groups of a HyPG molecule were esterified with methacryloyl groups. Under the selected conditions, the reaction reached an equilibrium within 4h. Furthermore, it was demonstrated that under the applied conditions the reaction was reversible. Hydrogels were obtained by crosslinking HyPG-MA in aqueous solutions using potassium peroxodisulfate (KPS) and N,N,N',N'-tetramethylethylenediamine (TEMED) as initiator and catalyst, respectively. Within 10min, 99% of the methacryloyl groups were polymerized. Rheological analysis showed that the storage modulus of these gels could be tailored by varying the concentration of HyPG-MA in the aqueous solution as well as by the DS. Moreover, the obtained hydrogels have a limited swelling capacity indicating that rather dimensionally stable networks were obtained. As an alternative for radical polymerization with KPS and TEMED, the HyPG-MA could also be crosslinked by photopolymerization using Irgacure 2959 as photoinitiator. A methacrylate conversion of 99% was obtained within 3min of illumination. As for the gels prepared with KPS and TEMED, networks formed by photopolymerization also had a high shear storage modulus and showed limited swelling. Hydrogels based on HyPG have great potential as drug delivery matrices and for tissue engineering purposes.

In Vitro Degradation Behavior of Microspheres Based on Cross-Linked Dextran

The aim of this study was to investigate the in vitro degradation of hydroxyl ethyl methacrylated dextran (dex-HEMA) microspheres. Dextran microspheres were incubated in phosphate buffer pH 7.4 at 37 degrees C, and the dry mass, mechanical strength, and chemical composition of the microspheres were monitored in time. The amount and nature of the formed degradation products were established for microspheres with different cross-link densities by FT-IR (Fourier transformed infrared spectroscopy), NMR, mass spectrometry, SEC analysis, and XPS (X-ray photoelectron microscopy). The dex-HEMA microspheres DS 12 (degree of HEMA substitution; the number of HEMA groups per 100 glucose units) incubated at pH 7.4 and 37 degrees C showed a continuous mass loss, leaving after 6 months a residue of about 10% (w/w) of water-insoluble products. NMR, mass spectrometry, and SEC showed that the water-soluble degradation products consisted of dextran, low molecular weight pHEMA (M(n) approximately 15 kg/mol), and small amounts of unreacted HEMA and HEMA-DMAP (intermediate reaction product of the Baylis-Hillman reaction of HEMA with DMAP (4-dimethyl aminopyridine)). Microscopy revealed that the water-insoluble residue consisted of particles with shape and size similar to that of nondegraded microspheres. However, these particles had lost their mechanical strength as evidenced from micromanipulation experiments. FT-IR and XPS (X-ray photoelectron microscopy) revealed that these particles consisted of pHEMA, of which a small fraction was soluble in methanol (M(n) ranging between 27 and 82 kg/mol). The insoluble material likely consisted of lightly cross-linked pHEMA. In conclusion, in vitro degradation of dex-HEMA microspheres results in the formation of water-soluble degradation products (mainly dextran), leaving a small water-insoluble residue mainly consisting of pHEMA.

Current advances in sustained-release systems for parenteral drug delivery

Major progresses in the development of parenteral sustained-release systems have been made in recent years as evidenced by the regulatory approval and market launch of several new products. Both the availability of novel carrier materials and the advances in method of fabrication have contributed to these commercial successes. With the formulation challenges associated with biologics, new delivery systems have also been evolved specifically to address the unmet needs in the parenteral sustained release of proteins. In this review paper, different new carriers systems and preparation methods are discussed with special focus on their applications to biologicals.